These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22394269)

  • 1. Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale.
    Fehr T; Gaspert A
    Transpl Int; 2012 Jun; 25(6):623-32. PubMed ID: 22394269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.
    Gupta G; Abu Jawdeh BG; Racusen LC; Bhasin B; Arend LJ; Trollinger B; Kraus E; Rabb H; Zachary AA; Montgomery RA; Alachkar N
    Transplantation; 2014 Jun; 97(12):1240-6. PubMed ID: 24937198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering antibody-mediated rejection: new insights into mechanisms and treatment.
    Stegall MD; Gloor JM
    Curr Opin Organ Transplant; 2010 Feb; 15(1):8-10. PubMed ID: 19890210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of therapeutic apheresis in the treatment of acute antibody-mediated kidney rejection.
    Ahmed T; Senzel L
    J Clin Apher; 2012; 27(4):173-7. PubMed ID: 22411078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection.
    Hardinger KL; Murillo D
    Clin Transpl; 2011; ():401-8. PubMed ID: 22755438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of antibody-mediated rejection in transplantation.
    Sadaka B; Alloway RR; Woodle ES
    Surg Clin North Am; 2013 Dec; 93(6):1451-66. PubMed ID: 24206861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.
    Walsh RC; Everly JJ; Brailey P; Rike AH; Arend LJ; Mogilishetty G; Govil A; Roy-Chaudhury P; Alloway RR; Woodle ES
    Transplantation; 2010 Feb; 89(3):277-84. PubMed ID: 20145517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of antibodies in kidney transplant].
    Ruffoni E; Seveso M; Marson P; Tison T; Cozzi E
    G Ital Nefrol; 2012; 29 Suppl 54():S54-60. PubMed ID: 22388831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.
    Waiser J; Budde K; Schütz M; Liefeldt L; Rudolph B; Schönemann C; Neumayer HH; Lachmann N
    Nephrol Dial Transplant; 2012 Mar; 27(3):1246-51. PubMed ID: 21852274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eculizumab treatment of acute antibody-mediated rejection in renal transplantation: case reports.
    González-Roncero F; Suñer M; Bernal G; Cabello V; Toro M; Pereira P; Angel Gentil M
    Transplant Proc; 2012 Nov; 44(9):2690-4. PubMed ID: 23146495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-mediated rejection in kidney transplantation: an update.
    Lucas JG; Co JP; Nwaogwugwu UT; Dosani I; Sureshkumar KK
    Expert Opin Pharmacother; 2011 Mar; 12(4):579-92. PubMed ID: 21294653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: Eculizumab rescue of severe accelerated antibody-mediated rejection after ABO-incompatible kidney transplant.
    Stewart ZA; Collins TE; Schlueter AJ; Raife TI; Holanda DG; Nair R; Reed AI; Thomas CP
    Transplant Proc; 2012 Dec; 44(10):3033-6. PubMed ID: 23195021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four-year allograft survival in a highly sensitized combined liver-kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib.
    Koch M; Gräser C; Lehnhardt A; Pollok JM; Kröger N; Verboom M; Thaiss F; Eiermann T; Nashan B
    Transpl Int; 2013 Aug; 26(8):e64-8. PubMed ID: 23672514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection.
    Fehr T; Rüsi B; Fischer A; Hopfer H; Wüthrich RP; Gaspert A
    Transplantation; 2009 Jun; 87(12):1837-41. PubMed ID: 19543061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive plasmapheresis and intravenous immunoglobulin for treatment of antibody-mediated rejection after kidney transplant.
    Ruangkanchanasetr P; Satirapoj B; Termmathurapoj S; Namkhanisorn K; Suaywan K; Nimkietkajorn V; Luesutthiviboon L
    Exp Clin Transplant; 2014 Aug; 12(4):328-33. PubMed ID: 25095710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of bortezomib for reducing donor-specific antibodies in children and adolescents on a steroid minimization regimen.
    Nguyen S; Gallay B; Butani L
    Pediatr Transplant; 2014 Aug; 18(5):463-8. PubMed ID: 24814755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation.
    Lee J; Kim BS; Park Y; Lee JG; Lim BJ; Jeong HJ; Kim YS; Huh KH
    Yonsei Med J; 2015 Nov; 56(6):1638-42. PubMed ID: 26446648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib rescue in refractory acute humoral rejection--report of a case.
    Shapiro R; Basu A; Zeevi A; Lunz J; Mapara M; Randhawa P; Morgan C; Tan HP; Sharma V
    Clin Transpl; 2009; ():431-2. PubMed ID: 20524310
    [No Abstract]   [Full Text] [Related]  

  • 19. Proteasome inhibitor treatment of antibody-mediated allograft rejection.
    Woodle ES; Alloway RR; Girnita A
    Curr Opin Organ Transplant; 2011 Aug; 16(4):434-8. PubMed ID: 21753709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options.
    Kim M; Martin ST; Townsend KR; Gabardi S
    Pharmacotherapy; 2014 Jul; 34(7):733-44. PubMed ID: 24753207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.